This content is no longer available for credit. Accreditation for this activity expired April 17, 2017.

Vulvodynia: A Common and Under-Recognized Pain Disorder in Women and Female Adolescents -- Integrating Current Knowledge into Clinical Practice

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   —  View entire article Previous | Next

*Nifedipine did not exceed placebo among women with vulvodynia in a double-blind study (107). Other topicals that are not useful include corticosteroids, progesterone, and antifungals (108).

 

 

 

 

 

 

Landry et al. provide a thorough review of surgical treatment studies (28).

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   —  View entire article Previous | Next